After growing for six years in a row, the worldwide medical technology (MedTech) market is now valued at over $587 billion. Notwithstanding this achievement, the industry is still under a lot of strain from growing input prices, stricter reimbursement guidelines, and a more complicated healthcare landscape. A recent report by Ernst and Young LLP (EY) indicates Looking ahead, the industry is encouraged by emerging opportunities in artificial intelligence and consumer engagement. As highlighted by EY’s findings, firms must adapt their commercial models to maintain growth amidst economic challenges. Investment in innovation capital remains crucial, though it currently accounts for just 44% of total financing—a drop from 67% during the peak of the COVID-19 pandemic. With focused portfolios and refined strategies, MedTech leaders are positioned to drive advancements in patient outcomes and sustain long-term growth.
